NIVF
NewGenIVF Group Ltd.
NASDAQ · Healthcare · Medical - Healthcare Plans · TH
$0.28
+1.47%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- $98
- Revenue estimate
- $45.1M
Latest reported
- Last report date
- Sep 2, 2026
- EPS actual
- $18
- EPS estimate
- $18
- Revenue actual
- $20.1M
- Revenue estimate
- $20.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -50.5%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 2, 2026 | $18 | $18 | In line | $20.1M |
| Jun 30, 2026 | $556 | -$6.06 | Miss -101.09% | $2.7M |
| Oct 9, 2025 | — | $13 | — | $2.0M |
| Sep 30, 2025 | — | $148 | — | $1.3M |
| Sep 29, 2024 | — | -$0.39 | — | $1.5M |
| Dec 30, 2023 | — | -$19 | — | $1.5M |
| May 30, 2021 | — | -$0.04 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027